Protecting Intestinal Barrier Health
Protecting Intestinal Barrier Health
Protectors of Intestinal Integrity
Science
Applying Established Science to Tackle New Challenges
We identify the role of intestinal barrier biology in human disease and develop novel therapeutics that target and improve the integrity of the intestinal barrier.
Our lead program LB1148 is currently being evaluated in a Phase 3 clinical study for accelerating the return of postoperative bowel function and a Phase 2 study for the prevention of post-surgical abdominal adhesions.
Science
Applying Established Science to Tackle New Challenges
We identify the role of intestinal barrier biology in human disease and develop novel therapeutics that target and improve the integrity of the intestinal barrier.
Our lead program LB1148 is currently being evaluated in a Phase 3 clinical study for accelerating the return of postoperative bowel function and a Phase 2 study for the prevention of post-surgical abdominal adhesions.
Research
Studying Impacts on Intestinal Integrity
Leveraging more than three decades of academic research and 15 years of our own internal efforts, we are advancing therapies to help patients with acute and chronic conditions associated with intestinal barrier disruption.
Research
Studying Impacts on Intestinal Integrity
Leveraging more than three decades of academic research and 15 years of our own internal efforts, we are advancing therapies to help patients with acute and chronic conditions associated with intestinal barrier disruption.
Investors and News
By developing new therapies to prevent damage and serious health conditions caused by intestinal barrier disruption, we can establish new standards of care for patients.